New Men B immunisation advice

Following recent high profile stories about child deaths from meningitis B, Public Health England has issued further advice:

Men B immunisation programme

Following recent media coverage about the death of a young girl from invasive meningococcal disease caused by Men B, many GP practices have had queries from parents about the availability of Men B immunisation. 

This information is taken from Public Health England publications and the GOV.UK website (see below for details).

What is the national policy for Men B immunisation?

The Men B immunisation programme started on 1 September 2015 for babies aged 2 months, ie, babies born on or after 1 July 2015.  There was a limited catch-up programme for babies born on or after 1 May 2015.  The routine schedule is for immunisation to be given at 2 and 4 months with the primaries, with a booster at 12 months.

Can I vaccinate children born before 1 May 2015 if parents request it? 

No. The national stock of Bexsero® should only be used to vaccinate children who are eligible for NHS vaccination.

Can I vaccinate children born on or after 1 May 2015 who have not yet been vaccinated?

Yes.  All children in the eligible cohort (ie, born on or after 1 May 2015) remain eligible for Men B immunisation until the age of two years. When Bexsero® has not been given as part of a primary course, give two doses at least two months apart. Those children who have received one dose before their first birthday only require one more dose. Please see the MenB PGD for more information.

If parents ask to pay for Men B immunisation for their children, what should I tell them?

GPs should not charge their own patients (ie, those registered at their practice) a private fee for the vaccine.

Parents seeking the vaccine privately should be made aware that they will be liable for the full costs of the vaccine and any additional administration charges that the private provider may apply. We understand that GSK has supply constraints on the Bexsero vaccine for the private market. Practices must not use centrally-procured stock for the national programme to vaccinate private patients or any patients outside the eligible cohort (other than those at high risk as defined in the green book).

Further information

Last updated : 16 Mar 2016

 

Training and development events (14 Oct 2015)

Londonwide Enterprise Ltd (the training arm of Londonwide LMCs) have been looking back over their work this year. The team have delivered 34 training sessions since January 2015, attracting 995...
Read more »

Quality and Outcomes (QOF) collection failure notice (14 Oct 2015)

The recent Quality and Outcomes Framework (QOF) information collection has not been successful due to a technical issue and the Health and Social Care Information Centre (HSCIC) is aware of...
Read more »

Speaker's Corner - Junior doctor contracts and why we should all be worried (14 Oct 2015)

This month Dr Ben Molyneux gives his views on the junior doctors contract dispute. Ben is a sessional GP and member of City & Hackney LMC. He is also a member...
Read more »

General Practitioners and mental health and well-being (14 Oct 2015)

At the halfway point in our series of mental well being masterclasses, workshop partner and PHP founder Dr Clare Gerada says the key challenge facing the NHS is GP...
Read more »

London GP Leader Calls for Recognition, Not Grand Schemes (07 Oct 2015)

Dr Michelle Drage, CEO of Londonwide LMCs - the representative body for GPs in London, has commented on the Secretary of State for Health's recent remarks about general practice: Statement...
Read more »

September newsletter now available (16 Sep 2015)

Londonwide LMCs Newsletter
Read more »

Life in general practice today – the Commonwealth Fund would like your views. (15 Sep 2015)

During the summer, the Commonwealth Fund in New York conducted a survey of GPs in the US and England to assess how front line doctors are feeling about practising...
Read more »
Next Page »
« Previous Page